Plant Summary
Plant Information
TCMBank_ID: | TCMBANKHE003756 |
ID: | TCMBANKHE003756 |
植物拉丁名: |
|
功能与主治: | See Acanthopanax gracilistylus./See Acanthopanax gracilistylus. |
药用植物名: | 无梗五加皮 |
药用部位: | root cortex |
TCM_ID_id: | 2983 |
植物对应的化合物
| 化合物ID | 化合物名 | 别名 | 分子式 | 分子质量 | Smiles |
|---|
| TCMBANKIN000056 | sesamol | LUSZGTFNYDARNI-UHFFFAOYSA-N; Sesamol, purum, >=98.0% (GC); NCGC00258763-01; SR-01000944738-1; Z1262246129; W-105747; NSC 59256; MCULE-8945575085; benzo[d][1,3]dioxol-5-ol; CHEMBL1517998; 533S313; S3003_ALDRICH; K-9668; DTXSID9021267; Tox21_201211; CTK3J6230; Sesamol, Vetec(TM) reagent grade, 98%; sesamol, ion (1+); BG00600287; ZB008171; Sesamol; AC-11668; AI3-17298; 3,4-(Methylenedioxy)-Phenol; DSSTox_GSID_21267; EBD8850; MFCD00005827; 3,4 Methylenedioxy Phenol; 3,4-methylenedioxy phenol; RTR-018861; 3,4-methylendioxy-phenol; 2H-benzo[d]1,3-dioxolen-5-ol; FT-0614403; 5-hydroxy-1,3-benzodioxolane; AC1Q6ZYU; 533-31-3; Phenol,4-(methylenedioxy)-; STOCK1N-66692; 4,5-methylenedioxyphenol; EINECS 208-561-5; NSC59256; AB1001909; MolPort-000-145-941; STK568334; Y0189; 2H-1,3-Benzodioxol-5-Ol; SY015819; 5-Hydroxy-1,3-benzodioxole; TR-018861; BG01497769; KB-64442; A25062; AKOS005493905; 3,4-(Methylenedioxy)phenol; 5-Benzodioxolol; NCGC00091628-02; InChI=1/C7H6O3/c8-5-1-2-6-7(3-5)10-4-9-6/h1-3,8H,4H; CAS-533-31-3; (3,4-methylenedioxy)phenol; Sesamol 10g; CS-0016841; Methylene ether of oxyhydroquinone; Sesamol, 98%; WLN: T56 BO DO CHJ GQ; BRN 0127405; SDCCGMLS-0066221.P001; BBL027539; Phenol, 3,4-(methylenedioxy)-; 85070_FLUKA; BDBM36291; NCGC00091628-01; 3,4-(Methylenedioxy)phenol; 5-hydroxylbenzo[1,3]dioxolane; ZINC00164504; sesamol sodium; Sesamol, analytical standard; DSSTox_RID_76047; BZX; ST5330663; 5-Benzodioxolol; I01-0893; SC-17690; 5-19-02-00532 (Beilstein Handbook Reference); benzo[1,3]dioxol-5-ol; 3,4-(Methylenedioxy)phenol; 1,3-Benzodioxol-5-ol; 5-Benzodioxolol; 3,4-Methylenedioxyphenol; ZINC164504; CHEBI:9126; sesamol lithium; 1,3-Benzodioxol-5-ol, 9CI; RP17328; KSC496E3B; S8518_SIGMA; 3,4-methylenedioxy-phenol; CCRIS 1386; DSSTox_CID_1267; 3,4-Methylendioxyphenol; AN-45647; AC1L29FS; sesamol titanium (+4); NSC-59256; F0001-1376; 5-Hydroxy-1, 3-benzodioxole; SCHEMBL20959; SR-01000944738; 5-Hydroxybenzo[1,3]dioxole; 1,3-Benzodioxol-5-ol (Sesamol); 1,3-Benzodioxol-5-ol; 5-Hydroxy-1,3-benzodioxole;5-Benzodioxolol;3,4-Methylendioxyphenol;3,4-methylenedioxyphenoL;3,4-(Methylenedioxy)phenol, sesamoL;1,3-Benzodioxol-5-ol; 1,2,4-Benzenetriol methylene ether; UNII-94IEA0NV89; 94IEA0NV89; C10832; AC1Q798T; 3ao1; ANW-43857; DB-021955; S0418; TL8003505; 5-hydroxy-benzo[1.3]dioxole; SBB085996; LS-2149; 1, 3-Benzodioxol-5-ol; ST50330663; GF-0128 | C7H6O3 | 138.12 | C1OC2=C(O1)C=C(C=C2)O |
| TCMBANKIN000962 | campesterol | campesterol ; FT-0082089; Augelicincampesterol; (24R)-5-Ergosten-3; (1R,3AS,3BR,9AS,9BS,11AR)-1-[(2R,5R)-5,6-DIMETHYLHEPTAN-2-YL]-9A,11A-DIMETHYL-1H,2H,3H,3AH,3BH,4H,5H,5AH,6H,9H,9BH,10H,11H-CYCLOPENTA[A]PHENANTHREN-7-OL; A-ol; 24(R)-Ergost-5-en-3beta-ol; 24alpha-Methyl-5-cholesten-3beta-ol; AK307302; SC-66911; (8R,9S,10S,13R,14S,17R)-17-((2R,5R)-5,6-Dimethylheptan-2-yl)-10,13-dimethyl-4,5,6,7,8,9,10,11,12,13,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-3-ol; AKOS027320474; MFCD00010475; Campesterin; MolPort-035-882-175 | C28H48O | 400.68 | CC(C)C(C)CCC(C)C1CCC2C1(CCC3C2CC=C4C3(CCC(C4)O)C)C |
| TCMBANKIN014618 | Campesteryl ferulate | campesteryl ferulate | C38H56O4 | 576.85 | CC(C)C(C)CCC(C)C1CCC2C1(CCC3C2CC=C4C3(CCC(C4)OC(=O)C=CC5=CC(=C(C=C5)O)OC)C)C |
| TCMBANKIN036829 | ursolic acid | ursolicacid; U6753_SIGMA; AIDS-039057; AKOS022168209; Urs-12-en-28-oic acid, 3beta-hydroxy- (8CI); 77-52-1; s2370; 3beta-Hydroxyurs-12-en-28-oic acid; SMR000445681; NSC4060; MLS000728569; Ursolic acid; TOS-BB-0966; 3beta-Hydroxy-12-ursen-28-ic acid; (1S,2R,4R,6aS,6bR,8aR,10S,12aR,12bR,14bR)-10-hydroxy-1,2,6a,6b,9,9,12a-heptamethyl-2,3,4,4a,5,6,6b,7,8,8a,9,10,11,12,12a,12b,13,14b-octadecahydro-1H-picene-4-carboxylic acid; ursolic acid ; BSPBio_000018; NSC 167406; H719; 89797_FLUKA; EINECS 201-034-0; Prunol; BPBio1_000020; (1S,2R,4aS,6aR,6aS,6bR,8aR,10S,12aR,14bS)-10-hydroxy-1,2,6a,6b,9,9,12a-heptamethyl-2,3,4,5,6,6a,7,8,8a,10,11,12,13,14b-tetradecahydro-1H-picene-4a-carboxylic acid; AI3-03109; CHEBI:9908; ST056289; Ursolicacid; AC-8029; Urs-12-en-28-oic acid, 3-hydroxy-, (3beta)-; Ursolic acid (Malol); CCRIS 7123; BC216337; Urson; (3beta)-3-Hydroxyurs-12-en-28-oic acid; Prestwick3_000089; Malol; C08988; AKOS015965499; SCHEMBL1699371; MolPort-016-633-342; 209545-05-1; AS-13246; AIDS039057; NSC 4060 | C30H48O3 | 456.7 | CC1CCC2(CCC3(C(=CCC4C3(CCC5C4(CCC(C5(C)C)O)C)C)C2C1C)C)C(=O)[O-] |
| TCMBANKIN037277 | Oleanolic acid | Olean-12-en-28-oic acid, 3.beta.-hydroxy-; s2334; Caryophyllin; AIDS014809; Giganteumgenin C; SMR000445561; oleanolicacid; (3-beta)-3-Hydroxyolean-12-en-28-oic acid; AIDS-014809; Olean-12-en-28-oic acid, 3-hydroxy-, (3-beta)-; EINECS 208-081-6; NSC 114945; OLEANOLIC ACID; Olean-12-en-28-oic acid, 3-hydroxy-, (3beta)-; CCRIS 6493; AS-11663; SCHEMBL1699365; Virgaureagenin B; CHEBI:37659; MLS000697656; (4aS,5S,6aS,6bR,8R,8aR,10S,12aR,12bR,14bS)-10-Hydroxy-2,2,6a,6b,9,9,12a-heptamethyl-1,3,4,5,6,6a,6b,7,8,8a,9,10,11,12,12a,12b,13,14b-octadecahydro-2H-picene-4a-carboxylic acid; AKOS022168208; O5504_SIGMA; MolPort-016-633-333; Oleanolic Acid; Olean-12-en-28-oic acid, 3-beta-hydroxy- (8CI); Oleanic acid; 3beta-Hydroxyolean-12-en-28-oic acid; 3-beta-Hydroxyolean-12-en-28-oic acid; ST057162; Olean-12-en-28-oic acid, 3beta-hydroxy- (8CI); NSC114945; Oleanolic Acid (Caryophyllin); Astrantiagenin C; Olean-12-en-28-oic acid, 3-hydroxy-, (3.beta.)-; 508-02-1; (4R,6aS,6bR,8aR,10S,12aR,12bR,14bR)-10-hydroxy-2,2,6a,6b,9,9,12a-heptamethyl-3,4,4a,5,6,7,8,8a,10,11,12,12b,13,14b-tetradecahydro-1H-picene-4-carboxylic acid; (4aS,6aR,6aS,6bR,8aR,10S,12aR,14bS)-10-hydroxy-2,2,6a,6b,9,9,12a-heptamethyl-1,3,4,5,6,6a,7,8,8a,10,11,12,13,14b-tetradecahydropicene-4a-carboxylic acid; oleanolic acid | C30H48O3 | 457 | C1([H])([H])C([H])([H])[C@](C([H])([H])[H])([C@@]([H])(C([H])([H])C([H])=C([C@@]([H])(C([H])([H])C(C([H])([H])[H])(C([H])([H])[H])C([H])([H])C2([H])[H])[C@@]2(C(=O)O[H])C([H])([H])C3([H])[H])[C@@]34C( [H])([H])[H])[C@@]4(C([H])([H])[H])C([H])([H])C5([H])[H])[C@@]5([H])C(C([H])([H])[H])(C([H])([H])[H])[C@@]1([H])O[H] |
| TCMBANKIN039199 | Chiisanogenin | 484.7 g/mol | |||
| TCMBANKIN040699 | Saxitoxin | BDBM190233; ZINC8552277; GTPL2625; DTXSID3074313; [(R,7aS,7bS)-2-amino-7,7-dihydroxy--imino-H,H,H,1H,5H,6H,7H,7bH-pyrrolo[1,2-c]purin--yl]methyl carbamate; SCHEMBL49687; SCHEMBL13028580; Saxitoxin in acetic acid (determination in mussel); [(3AS,4R,10AS)-2,6-DIAMINO-10,10-DIHYDROXY-1H,3AH,4H,8H,9H-PYRROLO[1,2-C]PURIN-4-YL]METHYL CARBAMATE; US9174999, Table 1, Compound 1; [(3AS,4R,10AS)-2-AMINO-10,10-DIHYDROXY-6-IMINO-3H,3AH,4H,5H,8H,9H-PYRROLO[1,2-C]PURIN-4-YL]METHYL CARBAMATE | 299.29 g/mol | ||
| TCMBANKIN047710 | chiisanoside | C48H74O19 | 955.09 | CC1C(C(C(C(O1)OC2C(OC(C(C2O)O)OCC3C(C(C(C(O3)OC(=O)C45CCC(C4C6CC7C8C(C6(CC5)C)(CCC(C8(C(CC(=O)O7)O)C)C(=C)C)C)C(=C)C)O)O)O)CO)O)O)O | |
| TCMBANKIN048097 | Acanthoside K3 | ||||
| TCMBANKIN048389 | Acanthoside K2 | ||||
| TCMBANKIN060259 | eleutheroside i | C41H66O11 | 735 g/mol | CC1C(C(C(C(O1)OC2COC(C(C2O)O)OC3CCC4(C(C3(C)C)CCC5(C4CC=C6C5(CCC7(C6CC(CC7)(C)C)C(=O)O)C)C)C)O)O)O | |
| TCMBANKIN060679 | stigmasterol | C29H48O | 412.7 g/mol | CCC(C=CC(C)C1CCC2C1(CCC3C2CC=C4C3(CCC(C4)O)C)C)C(C)C | |
| TCMBANKIN060680 | stigmasterol-3-glucoside | C35H58O6 | 574.83 g/mol | CCC(C=CC(C)C1CCC2C1(CCC3C2CC=C4C3(CCC(C4)OC5C(C(C(C(O5)CO)O)O)O)C)C)C(C)C | |
| TCMBANKIN060691 | poriferast-5-en-3beta-ol;22,23-dihydrostigmasterol;gamma-sitosterol;clionasterol;beta-dihydrofucosterol | C29H50O | 414.71 g/mol | CCC(CCC(C)C1CCC2C1(CCC3C2CC=C4C3(CCC(C4)O)C)C)C(C)C | |
| TCMBANKIN060693 | Sitogluside | C35H60O6 | 576.85g/mol | CCC(CCC(C)C1CCC2C1(CCC3C2CC=C4C3(CCC(C4)OC5C(C(C(C(O5)CO)O)O)O)C)C)C(C)C | |
| TCMBANKIN061762 | syringaresinol | (+)-Suyringaresinol-di-O-beta-D-glucoside_qt; (+)syringaresinol; (+)-Suyringaresinol-di-O-beta-D-glucoside; liriodendrin_qt; dl-Syringaresinol; syringaresinol diglucoside_qt; dl-sy-ringaresinol; (+)-syringaresinol-O-β-D-glucopyranoside; (+ )-syringaresinol; 4-[(1S,3aR,4S,6aR)-4-(4-hydroxy-3,5-dimethoxy-phenyl)-1,3,3a,4,6,6a-hexahydrofuro[4,3-c]furan-1-yl]-2,6-dimethoxy-phenol; 21453-69-0; C10889; (7alpha,7'alpha,8alpha,8'alpha)-3,3',5,5'-tetramethoxy-7,9':7',9-diepoxylignane-4,4'-diol; CHEBI:47; 4-[(1S,3aR,4S,6aR)-4-(4-hydroxy-3,5-dimethoxyphenyl)-1,3,3a,4,6,6a-hexahydrofuro[4,3-c]furan-1-yl]-2,6-dimethoxyphenol; (+)-syringaresinol; (+ )- syringaresinol; dl-syringaresinol; (-)-syringaresinol; episyringaresinol; (+)-syringarosinol; (+ )-Syringaresinol-O-β-D-glucopyranoside; syringaresino; (-)-syringaresinol; (?)-syringaresinol; (+)-Syringaresinol; lirioresinol-A | C34H46O18 | 742.72 | COC1=CC(=CC(=C1O)OC)C2C3COC(C3CO2)C4=CC(=C(C(=C4)OC)O)OC |
| TCMBANKIN061764 | Acanthoside B;(+)-Syringaresinol-O-beta-D-glucoside | ACon1_001107; (7alpha,7'alpha,8alpha,8'alpha)-4'-(beta-D-glucopyranosyloxy)-3,3',5,5'-tetramethoxy-7,9':7',9-diepoxylignan-4-ol; (2S,3R,4S,5S,6R)-2-[4-[(1S,3aR,4S,6aR)-4-(4-hydroxy-3,5-dimethoxyphenyl)-1,3,3a,4,6,6a-hexahydrofuro[4,3-c]furan-1-yl]-2,6-dimethoxyphenoxy]-6-(hydroxymethyl)oxane-3,4,5-triol; (2S,3R,4S,5S,6R)-2-[4-[(1S,3aR,4S,6aR)-4-(4-hydroxy-3,5-dimethoxy-phenyl)-1,3,3a,4,6,6a-hexahydrofuro[4,3-c]furan-1-yl]-2,6-dimethoxy-phenoxy]-6-methylol-tetrahydropyran-3,4,5-triol; 7374-79-0; (+)-syringaresinol beta-D-glucoside; (+)-Syringaresinol O-beta-D-glucoside; acanthoside b; C10890; (2S,3R,4S,5S,6R)-2-[4-[(1S,3aR,4S,6aR)-4-(4-hydroxy-3,5-dimethoxy-phenyl)-1,3,3a,4,6,6a-hexahydrofuro[4,3-c]furan-1-yl]-2,6-dimethoxy-phenoxy]-6-(hydroxymethyl)oxane-3,4,5-triol; beta-D-Glucopyranoside, 2,6-dimethoxy-4-(tetrahydro-4-(4-hydroxy-3,5-dimethoxyphenyl)-1H,3H-furo(3,4-c)furan-1-yl)phenyl, (1S-(1alpha,3aalpha,4a,6aalpha))-; (2S,3R,4S,5S,6R)-2-[4-[(1S,3aR,4S,6aR)-4-(4-hydroxy-3,5-dimethoxy-phenyl)-1,3,3a,4,6,6a-hexahydrofuro[4,3-c]furan-1-yl]-2,6-dimethoxy-phenoxy]-6-(hydroxymethyl)tetrahydropyran-3,4,5-triol; CHEBI:28603; (2S,3R,4S,5S,6R)-2-[4-[(1S,3aR,4S,6aR)-4-(4-hydroxy-3,5-dimethoxyphenyl)-1,3,3a,4,6,6a-hexahydrofuro[4,3-c]furan-1-yl]-2,6-dimethoxyphenoxy]-6-(hydroxymethyl)tetrahydropyran-3,4,5-triol; MEGxp0_000366;(+)-syringaresinol-o-beta-d-glucopyranoside | C28H36O13 | 580.58 | COC1=CC(=CC(=C1O)OC)C2C3COC(C3CO2)C4=CC(=C(C(=C4)OC)OC5C(C(C(C(O5)CO)O)O)O)OC |
植物对应的疾病
| 疾病ID | 病名 | 疾病类型 | MeSH | 参考文献 |
|---|
植物对应的靶点
| 靶点ID | 基因名 | 基因别名 | 描述 | 染色体位置 | Map_Location | 基因类型 |
|---|
滇ICP备16009434号-1 |
Dai SX Lab